REPLIGEN CORP (RGEN) › Cash & EquivalentsREPLIGEN CORP (RGEN) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2009: $5.04M2010: $9.79M2011: $11.17M2012: $29.21M2013: $39.83M2014: $35.36M2015: $54.09M2016: $122.23M2017: $173.76M2018: $193.82M2019: $528.39M2020: $717.29M2021: $603.81M2022: $523.46M2023: $751.32M2024: $757.36M2025: $566.02M$566.02M2009Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$566.02M-25.3%2024$757.36M+0.8%2023$751.32M+43.5%2022$523.46M-13.3%2021$603.81M-15.8%2020$717.29M+35.7%2019$528.39M+172.6%2018$193.82M+11.5%2017$173.76M+42.2%2016$122.23M+126.0%2015$54.09M+53.0%2014$35.36M-11.2%2013$39.83M+36.4%2012$29.21M+161.6%2011$11.17M+14.0%2010$9.79M+94.3%2009$5.04M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share